Clinical trials
Phase 2 Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 15 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute for Neurodegenerative Disorders | 4 |
| National Cancer Institute (NCI) | 3 |
| Dey | 2 |
| M.D. Anderson Cancer Center | 2 |
| Sanofi | 2 |
| Seattle Institute for Biomedical and Clinical Research | 2 |
| University of California, San Francisco | 2 |
| AbbVie | 1 |
| Akiva Cohen | 1 |
| American Scitech International | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 59 |
| Parkinsonian Disorders | 4 |
| Asthma | 3 |
| Breast Neoplasms | 3 |
| COVID-19 | 3 |
| Glioma | 3 |
| Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Alcoholism | 2 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.